Literature DB >> 29761308

Can positron emission tomography help stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?

G Neal Kay1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29761308     DOI： 10.1007/s12350-018-1299-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  36 in total

Review 1.  Abnormalities of the coronary circulation associated with left ventricular hypertrophy.

Authors:  D J O'Gorman; D J Sheridan
Journal:  Clin Sci (Lond)       Date:  1991-12       Impact factor: 6.124

2.  Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy.

Authors:  I Olivotto; B J Maron; A Montereggi; F Mazzuoli; A Dolara; F Cecchi
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

3.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

4.  Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

Authors:  C Basso; G Thiene; D Corrado; G Buja; P Melacini; A Nava
Journal:  Hum Pathol       Date:  2000-08       Impact factor: 3.466

5.  Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy.

Authors:  Paul Sorajja; Rick A Nishimura; Steve R Ommen; Michael J Ackerman; A Jamil Tajik; Bernard J Gersh
Journal:  J Am Soc Echocardiogr       Date:  2006-06       Impact factor: 5.251

6.  Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia.

Authors:  W C Roberts; V J Ferrans
Journal:  Hum Pathol       Date:  1975-05       Impact factor: 3.466

7.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

8.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

9.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Win-Kuang Shen; Tammy S Haas; Francesco Formisano; Mark S Link; Andrew E Epstein; Adrian K Almquist; James P Daubert; Thorsten Lawrenz; Giuseppe Boriani; N A Mark Estes; Stefano Favale; Marco Piccininno; Stephen L Winters; Massimo Santini; Sandro Betocchi; Fernando Arribas; Mark V Sherrid; Gianfranco Buja; Christopher Semsarian; Paolo Bruzzi
Journal:  JAMA       Date:  2007-07-25       Impact factor: 56.272

10.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.

Authors:  Lubna Choudhury; Heiko Mahrholdt; Anja Wagner; Kelly M Choi; Michael D Elliott; Francis J Klocke; Robert O Bonow; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2002-12-18       Impact factor: 24.094
View more
  1 in total

1.  Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.

Authors:  Peter Magnusson; Jonny Nordström; Hendrik J Harms; Mark Lubberink; Fredrik Gadler; Jens Sörensen; Stellan Mörner
Journal:  Int J Cardiol Heart Vasc       Date:  2019-12-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.